Delving into the Latest Updates on GB001, Inc. with Synapse

概览

关联

5

项与 GB001, Inc. 相关的临床试验

EUCTR2019-001682-33-CZ / Not yet recruiting临床2期

A Phase 2a, randomized, double-blind, placebo-controlled, multi-center study to evaluate the effect of GB001 in patients with chronic rhinosinusitis with or without nasal polyps

开始日期2019-09-09

申办/合作机构

GB001, Inc.

NCT03956862 / Completed临床2期

A Phase 2a, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Effect of GB001 in Patients With Chronic Rhinosinusitis With or Without Nasal Polyps

A Phase 2a, randomized, double-blind, placebo-controlled, multi-center study to evaluate the efficacy, safety, pharmacokinetics (PK), and pharmacodynamics (PD) of GB001 compared with placebo over 16 weeks of treatment in patients with chronic rhinosinusitis with or without nasal polyposis (NP).

开始日期2019-05-16

申办/合作机构

GB001, Inc.

EUCTR2018-002242-36-DE / Not yet recruiting临床2期

A Phase 2b, randomized, double-blind, placebo-controlled, dose-ranging, multi-center study to evaluate the efficacy and safety of GB001 as maintenance therapy in adult subjects with moderate to severe asthma

开始日期2018-12-17

申办/合作机构

GB001, Inc.

100 项与 GB001, Inc. 相关的临床结果

登录后查看更多信息

0 项与 GB001, Inc. 相关的专利（医药）

登录后查看更多信息

100 项与 GB001, Inc. 相关的药物交易

登录后查看更多信息

100 项与 GB001, Inc. 相关的转化医学

登录后查看更多信息